Ireland
--:--IST
Latest
Clinical Trials in Israel / NCT07048340
Recruiting Not applicable

Cognitive-behavioral Therapy for Insomnia in School-aged Children

NCT07048340 · tracked via the Priya Life Science Israel tracker
Phase
Not applicable
Started
2025-07-10
Last updated
2025-09-18

Condition(s) studied

Insomnia

Investigational drug(s) / intervention(s)

Cognitive Behavioral Therapy for InsomniaCognitive Behavioral Therapy for Insomnia without SRT

Cognitive Behavioral Therapy for Insomnia: CBT-I intervention will include four 45-60 minute sessions with a clinician. The sessions will include CBT-I components such as sleep psychoeducation, bedtime routines and sleep hygiene, graduated exposure, cognitive restructuring, and SRT in one of the intervention groups. The protocol is based on previous studies of CBT-I for school-aged children.

Cognitive Behavioral Therapy for Insomnia without SRT: This intervention will include four 45-60 minute sessions with a clinician. The sessions will include CBT-I components such as sleep psychoeducation, bedtime routines and sleep hygiene, graduated exposure, and cognitive restructuring. Sleep Restriction Therapy will not be included in the intervention. The protocol is based on previous studies that delivered CBT-I to school-aged children.

Study summary

This randomized controlled trial will test the efficacy of CBT-I intervention for school-aged children (7-11 years old) with insomnia. The trial will focus on the role of sleep restriction therapy in treatment. Children will be randomized to one of three groups: (1) CBT-I; (2) CBT-I without SRT; or (3) a waitlist control group. Assessments will occur at baseline, mid-treatment, post-treatment, and a 3-month follow up. Some measures (e.g., child motivation) will also be assessed after each therapy session. Insomnia and sleep-wake patterns will be assessed objectively using actigraphy, and subjectively using sleep diaries, a clinical diagnostic interview, and questionnaires. Parent and child questionnaires will be administered to assess moderators and mediators of treatment outcomes.

Eligibility

Sex
ALL
Min age
7 Years
Max age
11 Years
Healthy volunteers
No
Inclusion Criteria: * Child aged 7-11 years * Parents aged over 18 years * Child meets the International Classification of Sleep Disorders - Third Edition (ICSD-3) criteria for chronic insomnia disorder with sleep difficulties occurring at least 3 times a week and lasting at least 3 months (Insomnia diagnosis will be determined during a clinical interview). Exclusion Criteria: * Child receiving concurrent CBT treatment for sleep or anxiety disorders. * Child diagnosed with a medical sleep problem (e.g., OSA, RLS) * Significant health or neurodevelopmental problems (e.g., intellectual disability) * Current psychotropic medications, or sleep aid medications * Lack of Hebrew reading and writing * Total sleep time that is shorter than 6 hours on average per night at baseline

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Tel Aviv University Tel Aviv Israel Recruiting

More Tel Aviv University trials in Israel

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07048340 on ClinicalTrials.gov ↗ ← All trials in Israel